Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelika Lueking

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|June 1, 2005
Protein biochips: A new and versatile platform technology for molecular medicineAngelika Lueking, Dolores J Cahill, Stefan Müllner
Current Pharmaceutical Design|November 1, 2006
New analytical tools for studying autoimmune diseasesMatthias Kalbas, Angelika Lueking, Axel Kowald, et al.
Trends in Molecular Medicine|June 18, 2002
High-throughput protein arrays: prospects for molecular diagnosticsGerald Walter, Konrad Büssow, Angelika Lueking, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
A dual-expression vector allowing expression in E. coli and P. pastoris, including new modificationsAngelika Lueking, Sabine Horn, Hans Lehrach, et al.
Biotechniques|October 16, 2008
Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarraysAngelika Lueking, Jens Beator, Elisabeth Patz, et al.
Biometrical Journal. Biometrische Zeitschrift|June 20, 2017
Multivariate binary classification of imbalanced datasets-A case study based on high-dimensional multiplex autoimmune assay dataLaura Schlieker, Anna Telaar, Angelika Lueking, et al.
Plos One|October 22, 2014
Aggregation of the protein TRIOBP-1 and its potential relevance to schizophreniaNicholas J Bradshaw, Verian Bader, Ingrid Prikulis, et al.
Journal of Neuroimmunology|December 20, 2011
Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosisNatascha Helena Beyer, Angelika Lueking, Axel Kowald, et al.
Analytical and Bioanalytical Chemistry|March 18, 2008
Off-target activity of TNF-alpha inhibitors characterized by protein biochipsOliver Feyen, Angelika Lueking, Axel Kowald, et al.
Advances in Biochemical Engineering/Biotechnology|September 14, 2002
Protein array technology: the tool to bridge genomics and proteomicsHolger Eickhoff, Zoltán Konthur, Angelika Lueking, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|June 1, 2005
Protein biochips: A new and versatile platform technology for molecular medicineAngelika Lueking, Dolores J Cahill, Stefan Müllner
Current Pharmaceutical Design|November 1, 2006
New analytical tools for studying autoimmune diseasesMatthias Kalbas, Angelika Lueking, Axel Kowald, et al.
Trends in Molecular Medicine|June 18, 2002
High-throughput protein arrays: prospects for molecular diagnosticsGerald Walter, Konrad Büssow, Angelika Lueking, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 21, 2002
A dual-expression vector allowing expression in E. coli and P. pastoris, including new modificationsAngelika Lueking, Sabine Horn, Hans Lehrach, et al.
Biotechniques|October 16, 2008
Determination and validation of off-target activities of anti-CD44 variant 6 antibodies using protein biochips and tissue microarraysAngelika Lueking, Jens Beator, Elisabeth Patz, et al.
Biometrical Journal. Biometrische Zeitschrift|June 20, 2017
Multivariate binary classification of imbalanced datasets-A case study based on high-dimensional multiplex autoimmune assay dataLaura Schlieker, Anna Telaar, Angelika Lueking, et al.
Plos One|October 22, 2014
Aggregation of the protein TRIOBP-1 and its potential relevance to schizophreniaNicholas J Bradshaw, Verian Bader, Ingrid Prikulis, et al.
Journal of Neuroimmunology|December 20, 2011
Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosisNatascha Helena Beyer, Angelika Lueking, Axel Kowald, et al.
Analytical and Bioanalytical Chemistry|March 18, 2008
Off-target activity of TNF-alpha inhibitors characterized by protein biochipsOliver Feyen, Angelika Lueking, Axel Kowald, et al.
Advances in Biochemical Engineering/Biotechnology|September 14, 2002
Protein array technology: the tool to bridge genomics and proteomicsHolger Eickhoff, Zoltán Konthur, Angelika Lueking, et al.
Pageof 3